TerminatedPhase 2NCT01682031
Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation Therapy
Studying Acute radiation syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Roswell Park Cancer Institute
- Principal Investigator
- Anurag SinghRoswell Park Cancer Institute
- Intervention
- selenomethionine(dietary_supplement)
- Enrollment
- 18 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2009 – 2012
Study locations (2)
- Roswell Park Cancer Institute, Buffalo, New York, United States
- Waikato Hospital, Hamilton, New Zealand
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01682031 on ClinicalTrials.govOther trials for Acute radiation syndrome
Additional recruiting or active studies for the same condition.